Synonyms: | |
Status: | Phase 3 |
Entry Type: | Antibody |
Molecule Category: | UKNOWN |
UNII: | VE267FC2UB |
Action | Mechanism of Action | Reference |
---|---|---|
ANTAGONIST | Insulin-like growth factor I receptor antagonist | PubMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Carcinoma, Squamous Cell | 3 | D002294 | ClinicalTrials |
Carcinoma, Large Cell | 3 | D018287 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
Head and Neck Neoplasms | 2 | D006258 | ClinicalTrials |
Lung Neoplasms | 1 | D008175 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Sarcoma | 1 | D012509 | ClinicalTrials |
Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Sarcoma, Ewing | 1 | D012512 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL1743019 |
FDA SRS | VE267FC2UB |